Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11084	Companies
243329	Keywords
171476	Articles
131037	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 04/17/2025 at 15:00, 1 year 5 months ago

Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress
Crofelemer, a plant-based prescription drug, granted Orphan Drug Designation by FDA & EMA for treating rare pediatric diseases, including short bowel syndrome (SBS) & microvillus inclusion disease (MVID). Study presented at ELITE PED-GI Congress

Crofelemer Orphan Drug Designation MVID SBS ELITE PED-GI Congress
BRIEF

published on 04/15/2025 at 15:35, 1 year 5 months ago

Jaguar Health's Promising Results for Breast Cancer Patients at MASCC Annual Meeting

Crofelemer Jaguar Health Breast Cancer Supportive Care FDA Discussions
BRIEF

published on 04/15/2025 at 15:35, 1 year 5 months ago

Résultats prometteurs de Jaguar Health pour les patientes atteintes d'un cancer du sein lors de la réunion annuelle du MASCC

Crofelemer Jaguar Health Cancer Du Sein Soins De Soutien Discussions De La FDA
PRESS RELEASE

published on 04/15/2025 at 15:30, 1 year 5 months ago

Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
Jaguar Health's crofelemer shows significant results in breast cancer patients for prophylaxis of diarrhea. Late-breaker abstracts on responder analysis and oral mucositis survey results accepted for MASCC's 2025 Annual Meeting

Crofelemer Jaguar Health Breast Cancer Diarrhea Prophylaxis MASCC
BRIEF

published on 04/08/2025 at 14:35, 1 year 5 months ago

Jaguar Health Showcases Gelclair at Oncology Nursing Society Congress

Cancer Care Jaguar Health Gelclair Oral Mucositis Oncology Nursing Society
BRIEF

published on 04/08/2025 at 14:35, 1 year 5 months ago

Jaguar Health présente Gelclair au congrès de l'Oncology Nursing Society

Jaguar Health Soins Contre Le Cancer Gelclair Mucite Buccale Société Des Soins Infirmiers En Oncologie
PRESS RELEASE

published on 04/08/2025 at 14:30, 1 year 5 months ago

Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Jaguar Health, Inc. (NASDAQ:JAGX) announces Napo Pharmaceuticals' participation in the 50th Oncology Nursing Society Congress to showcase Gelclair® for oral mucositis relief in cancer patients

Napo Pharmaceuticals Cancer Care Jaguar Health Gelclair Oral Mucositis
BRIEF

published on 04/04/2025 at 22:20, 1 year 5 months ago

Jaguar Health Awards New Employee Inducement Grants

Stock Options Restricted Stock Units Jaguar Health Nasdaq Listing Rule Employee Inducement
BRIEF

published on 04/04/2025 at 22:20, 1 year 5 months ago

Jaguar Health attribue des subventions d'incitation aux nouveaux employés

Jaguar Health Unités D'actions Restreintes Options Sur Actions Incitation Des Employés Règle De Cotation Au Nasdaq
PRESS RELEASE

published on 04/04/2025 at 22:15, 1 year 5 months ago

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. grants RSUs and stock options to new employees and outlines vesting terms. Also, provides an overview of the Jaguar Health Family of Companies' focus

Stock Options Jaguar Health RSUs New Employees Vesting Terms

Accesswire

Published on 09/26/2026 at 01:00, 2 days 6 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 2 days 6 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 9 hours ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 14 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 16 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/28/2026 at 07:13, 22 minutes ago

Cameo Resources: High-Tech Gold Hunt in the Shadow of AngloGold!
Published on 09/28/2026 at 07:05, 30 minutes ago

Arcadis deepens Autodesk collaboration to accelerate AI and data-led delivery for clients
Published on 09/28/2026 at 07:00, 35 minutes ago

DKSH and Grünenthal Announce New Partnership Agreement to Accelerate Access to Innovative Pain Management Solutions Across Eight Markets in Asia-Pacific
Published on 09/28/2026 at 06:45, 50 minutes ago

HBM Healthcare Investments Increases Its Stake in Portfolio Company ADARx Pharmaceuticals Through IPO
Published on 09/28/2026 at 06:20, 1 hour 15 minutes ago

Aurra Markets Crowned 'Best Emerging Broker' at Forex Expo Dubai 2026

Les Echos

Published on 09/26/2026 at 07:00, 2 days ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 2 days 13 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 2 days 13 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 2 days 13 hours ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 13 hours ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE